Rhythm Pharmaceuticals Operating Expenses 2011-2026 | RYTM

Annual Operating Expenses Rhythm Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	146 M	78.4 M	32.4 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
146 M	32.4 M	85.6 M

Quarterly Operating Expenses Rhythm Pharmaceuticals

2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	34.3 M	31.9 M	35.3 M	34.2 M	37.1 M	44.1 M	30.5 M	27.2 M	19.2 M	15 M	17 M	11 M	8.29 M	6.75 M	6.39 M	8.38 M	6.4 M	5.74 M	5.39 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
44.1 M	5.39 M	20.2 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Esperion Therapeutics ESPR	343 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 32.59	-6.89 %	$ 877 M	USA
Forte Biosciences FBRX	70.7 M	$ 21.59	-1.86 %	$ 280 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
BioNTech SE BNTX	512 M	$ 92.14	1.33 %	$ 22.3 B	Germany
Grifols, S.A. GRFS	1.64 B	$ 7.98	-1.6 %	$ 5.42 B	Spain
Autolus Therapeutics plc AUTL	145 M	$ 1.7	3.03 %	$ 452 M	Britain
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	281 M	$ 0.86	-1.42 %	$ 143 M	USA
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Compugen Ltd. CGEN	32.2 M	$ 2.8	7.28 %	$ 262 M	Israel
Anika Therapeutics ANIK	51.6 M	$ 14.88	-0.93 %	$ 213 M	USA
Advaxis ADXS	19.6 M	-	-9.65 %	$ 45.9 M	USA
Incyte Corporation INCY	1.62 B	$ 97.16	-0.26 %	$ 19 B	USA
Ionis Pharmaceuticals IONS	752 M	$ 75.56	-0.29 %	$ 12.1 B	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.4	-1.16 %	$ 5.6 M	Israel
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	231 M	$ 1.61	2.55 %	$ 189 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	305 M	$ 20.86	-0.71 %	$ 2.65 B	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA